RxSight Inc (NAS:RXST)
$ 4.95 -0.14 (-2.85%) Market Cap: 204.91 Mil Enterprise Value: -2.14 Mil PE Ratio: 0 PB Ratio: 0.77 GF Score: 68/100

Preliminary Q2 2025 Rxsight Inc Earnings Call Transcript

Jul 8, 2025 / 09:00 PM GMT
Release Date Price: $12.79 (+2.90%)

Key Points

Positve
  • RxSight Inc (RXST) has implemented a commercial pivot to address the decline in LAL utilization, focusing on clinical support, education, and value-added engagement efforts.
  • The company is leveraging unique analytics to drive sustainable same-store sales and new customer commitment.
  • RxSight Inc (RXST) has increased its gross margin guidance to 72%-74%, up from the previous range of 71%-73%, due to a shift in revenue mix towards higher-margin LAL sales.
  • The company is expanding its peer-to-peer programs to support practices at every stage of the LAL adoption journey, enhancing expertise and engagement.
  • RxSight Inc (RXST) is confident in its strategic priorities to unlock the full potential of its platform, supported by a strong balance sheet and a best-in-class field organization.
Negative
  • RxSight Inc (RXST) reported a significant decline in LDD sales, down 49% from the previous year and 45% from the previous quarter.
  • The company revised its full-year 2025 revenue guidance downwards, now expecting a decrease of 14% to 7% compared to 2024.
  • LAL utilization was down about 21% year over year in Q2, with guidance implying further declines in the second half of the year.
  • Newer customers are adopting more slowly than previous ones, requiring more support to move up the adoption curve.
  • The company faces competitive pressures from new product launches in the multifocal lens space, impacting its market share.


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

RXST.OQ - Rxsight Inc
Preliminary Q2 2025 Rxsight Inc Earnings Call
Jul 08, 2025 / 09:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Thank you for standing by. My name is Eric, and I will be a conference operator today.

At this time, I would like to welcome everyone to the RX site Q2 pre-announced earnings call.

All lines have been placed on mute to prevent any background noise.

After the speaker's remarks, there will be a question and answer session. If you would like to ask a question during this time, simply press start, followed by the number one on your telephone keypad.

If you'd like to withdraw your question, press start one again.

I would now like to turn the call over to Oliver Moratovich, Vice President of Investor relations. Please go ahead.

--------------------------------------------------------------
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot